HAI
AZN icon

Hennessy Advisors Inc’s AstraZeneca AZN Stock Holding History

Hennessy Advisors Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-88,800
Closed -$6.16M – 353
2017
Q4 		$6.16M Hold
88,800
– – 0.19% 117
2017
Q3 		$6.02M Hold
88,800
– – 0.19% 115
2017
Q2 		$6.05M Sell
88,800
-3,100
-3% -$202K 0.19% 98
2017
Q1 		$5.72M Buy
+91,900
New +$5.35M 0.17% 107

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hennessy Advisors Inc's AZN Position: Q1 2018 in Review

Hennessy Advisors Inc sold out of AstraZeneca (AZN) in Q1 2018, closing a stake of 88,800 shares — an estimated $6.16M sold.

Hennessy Advisors Inc first reported a position in AZN in Q1 2017 and held it in 4 quarters. The position peaked at $6.16M in Q4 2017. 519 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

  • Hennessy Advisors Inc reported no remaining AstraZeneca position as of Q1 2018 after selling out during the quarter.
  • Hennessy Advisors Inc sold 88,800 AstraZeneca shares in Q1 2018, an estimated $6.16M.
  • Hennessy Advisors Inc first reported a position in AstraZeneca in Q1 2017 and held it in 4 quarters.
  • Hennessy Advisors Inc's AstraZeneca position peaked at $6.16M in Q4 2017.
  • 519 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Hennessy Advisors Inc's 13F filing for Q1 2018, filed 2 May 2018.